• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

甲状腺乳头状癌细胞中外泌体微小RNA及其靶标的鉴定

Identification of Exosomal microRNAs and Their Targets in Papillary Thyroid Cancer Cells.

作者信息

Maggisano Valentina, Capriglione Francesca, Verrienti Antonella, Celano Marilena, Gagliardi Agnese, Bulotta Stefania, Sponziello Marialuisa, Mio Catia, Pecce Valeria, Durante Cosimo, Damante Giuseppe, Russo Diego

机构信息

Department of Health Sciences, University "Magna Graecia" of Catanzaro, 88100 Catanzaro, Italy.

Department of Translational and Precision Medicine, "Sapienza" University of Rome, 00161 Rome, Italy.

出版信息

Biomedicines. 2022 Apr 21;10(5):961. doi: 10.3390/biomedicines10050961.

DOI:10.3390/biomedicines10050961
PMID:35625697
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9138952/
Abstract

The release of molecules in exosomal cargoes is involved in tumor development and progression. We compared the profiles of exosomal microRNAs released by two thyroid cancer cell lines (TPC-1 and K1) with that of non-tumorigenic thyroid cells (Nthy-ori-3-1), and we explored the network of miRNA-target interaction. After extraction and characterization of exosomes, expression levels of microRNAs were investigated using custom TaqMan Advanced array cards, and compared with those expressed in the total cell extracts. The functional enrichment and network-based analysis of the miRNAs' targets was also performed. Five microRNAs (miR-21-5p, miR-31-5p, miR-221-3p, miR-222-3p, and let-7i-3p) were significantly deregulated in the exosomes of tumor cells vs. non-tumorigenic cells, and three of them (miR-31-5p, miR-222-3p, and let-7i-3p) in the more aggressive K1 compared to TPC-1 cells. The network analysis of the five miRNAs identified some genes as targets of more than one miRNAs. These findings permitted the identification of exosomal microRNAs secreted by aggressive PTC cells, and indicated that their main targets are regulators of the tumor microenvironment. A deeper analysis of the functional role of the targets of exosomal miRNAs will provide further information on novel targets of molecular treatments for these neoplasms.

摘要

外泌体货物中分子的释放参与肿瘤的发生和发展。我们比较了两种甲状腺癌细胞系(TPC-1和K1)与非致瘤性甲状腺细胞(Nthy-ori-3-1)释放的外泌体微小RNA谱,并探索了miRNA-靶标相互作用网络。在提取和鉴定外泌体后,使用定制的TaqMan Advanced阵列卡研究微小RNA的表达水平,并与全细胞提取物中表达的水平进行比较。还对miRNA靶标进行了功能富集和基于网络的分析。与非致瘤性细胞相比,肿瘤细胞外泌体中有5种微小RNA(miR-21-5p、miR-31-5p、miR-221-3p、miR-222-3p和let-7i-3p)显著失调,其中3种(miR-31-5p、miR-222-3p和let-7i-3p)在侵袭性更强的K1细胞中与TPC-1细胞相比失调更明显。对这5种微小RNA的网络分析确定了一些基因是不止一种微小RNA的靶标。这些发现有助于鉴定侵袭性乳头状甲状腺癌细胞分泌的外泌体微小RNA,并表明它们的主要靶标是肿瘤微环境的调节因子。对外泌体微小RNA靶标的功能作用进行更深入分析将为这些肿瘤分子治疗的新靶标提供更多信息。

相似文献

1
Identification of Exosomal microRNAs and Their Targets in Papillary Thyroid Cancer Cells.甲状腺乳头状癌细胞中外泌体微小RNA及其靶标的鉴定
Biomedicines. 2022 Apr 21;10(5):961. doi: 10.3390/biomedicines10050961.
2
Identification of exosomal miRNA biomarkers for diagnosis of papillary thyroid cancer by small RNA sequencing.通过小 RNA 测序鉴定用于诊断甲状腺乳头状癌的外泌体 miRNA 生物标志物。
Eur J Endocrinol. 2020 Jan;182(1):111-121. doi: 10.1530/EJE-19-0524.
3
Differential expression of exosomal microRNAs in fresh and senescent apheresis platelet concentrates.新鲜和衰老单采血小板浓缩物中外泌体微小RNA的差异表达
Platelets. 2022 Nov 17;33(8):1260-1269. doi: 10.1080/09537104.2022.2108541. Epub 2022 Aug 14.
4
Analysis of serum microRNA in exosomal vehicles of papillary thyroid cancer.甲状腺乳头癌囊泡外体血清 microRNA 分析。
Endocrine. 2022 Jan;75(1):185-193. doi: 10.1007/s12020-021-02847-2. Epub 2021 Aug 10.
5
Aberrant expression profiles and bioinformatic analysis of CAF-derived exosomal miRNAs from three moderately differentiated supraglottic LSCC patients.三名中分化声门上型喉癌患者的 CAF 衍生外泌体 miRNA 的异常表达谱和生物信息学分析。
J Clin Lab Anal. 2022 Jan;36(1):e24108. doi: 10.1002/jcla.24108. Epub 2021 Nov 17.
6
Plasma Exosomal miR-146b-5p and miR-222-3p are Potential Biomarkers for Lymph Node Metastasis in Papillary Thyroid Carcinomas.血浆外泌体miR-146b-5p和miR-222-3p是甲状腺乳头状癌淋巴结转移的潜在生物标志物。
Onco Targets Ther. 2020 Feb 13;13:1311-1319. doi: 10.2147/OTT.S231361. eCollection 2020.
7
Papillary thyroid cancer-derived exosomes contain miRNA-146b and miRNA-222.甲状腺乳头状癌来源的外泌体含有miRNA - 146b和miRNA - 222。
J Surg Res. 2015 Jun 1;196(1):39-48. doi: 10.1016/j.jss.2015.02.027. Epub 2015 Feb 19.
8
MicroRNA-146b-3p Promotes Cell Metastasis by Directly Targeting in Human Papillary Thyroid Cancer.miR-146b-3p 通过直接靶向在人甲状腺乳头状癌中促进细胞转移。
Thyroid. 2018 Dec;28(12):1627-1641. doi: 10.1089/thy.2017.0626. Epub 2018 Oct 27.
9
Exosomal onco-miRs from serum of patients with adenocarcinoma of the esophagus: comparison of miRNA profiles of exosomes and matching tumor.食管癌患者血清中的外泌体致癌miR:外泌体与匹配肿瘤的miRNA谱比较
Tumour Biol. 2015 Jun;36(6):4643-53. doi: 10.1007/s13277-015-3112-0. Epub 2015 Jan 29.
10
A Panel of Plasma Exosomal miRNAs as Potential Biomarkers for Differential Diagnosis of Thyroid Nodules.一组血浆外泌体微小RNA作为甲状腺结节鉴别诊断的潜在生物标志物
Front Genet. 2020 May 19;11:449. doi: 10.3389/fgene.2020.00449. eCollection 2020.

引用本文的文献

1
Exosomes: innovative biomarkers leading the charge in non-invasive cancer diagnostics.外泌体:引领非侵入性癌症诊断的创新生物标志物。
Theranostics. 2025 Apr 13;15(11):5277-5311. doi: 10.7150/thno.113650. eCollection 2025.
2
Navigating thyroid cancer complexity: the emerging role of EV-derived non-coding RNAs.应对甲状腺癌的复杂性:细胞外囊泡衍生的非编码RNA的新作用
Cell Death Discov. 2025 Apr 4;11(1):142. doi: 10.1038/s41420-025-02411-1.
3
Could Be a Promising Marker for Preoperative Diagnosis of High-Grade Papillary Thyroid Carcinoma?

本文引用的文献

1
MiR-221-3p Facilitates Thyroid Cancer Cell Proliferation and Inhibit Apoptosis by Targeting FOXP2 Through Hedgehog Pathway.miR-221-3p 通过靶向 Hedgehog 通路抑制 FOXP2 促进甲状腺癌细胞增殖并抑制凋亡。
Mol Biotechnol. 2022 Aug;64(8):919-927. doi: 10.1007/s12033-022-00473-5. Epub 2022 Mar 7.
2
Communication between cells: exosomes as a delivery system in prostate cancer.细胞间通讯:外泌体作为前列腺癌的一种递药系统。
Cell Commun Signal. 2021 Nov 12;19(1):110. doi: 10.1186/s12964-021-00792-1.
3
Papillary Thyroid Cancer Prognosis: An Evolving Field.
能否成为高级别乳头状甲状腺癌术前诊断的有前景的标志物?
Diagnostics (Basel). 2024 Nov 25;14(23):2652. doi: 10.3390/diagnostics14232652.
4
The Application of microRNAs in Papillary Thyroid Cancer: A Bibliometric and Visualized Analysis.微小RNA在甲状腺乳头状癌中的应用:文献计量学与可视化分析
Int J Gen Med. 2024 Oct 15;17:4681-4699. doi: 10.2147/IJGM.S487239. eCollection 2024.
5
Exosome-Mediated Communication in Thyroid Cancer: Implications for Prognosis and Therapeutic Targets.外泌体介导的甲状腺癌细胞间通讯:对预后和治疗靶点的影响
Biochem Genet. 2024 Jun 5. doi: 10.1007/s10528-024-10833-2.
6
RNA Profile of Cell Bodies and Exosomes Released by Tumorigenic and Non-Tumorigenic Thyroid Cells.肿瘤细胞和非肿瘤细胞释放的细胞体和外泌体的 RNA 谱。
Int J Mol Sci. 2024 Jan 24;25(3):1407. doi: 10.3390/ijms25031407.
7
Expression of miR-31-5p affects growth, migration and invasiveness of papillary thyroid cancer cells.miR-31-5p 的表达影响甲状腺乳头状癌细胞的生长、迁移和侵袭能力。
Endocrine. 2023 Mar;79(3):517-526. doi: 10.1007/s12020-022-03267-6. Epub 2022 Dec 7.
8
Role of Extracellular Vesicles in Thyroid Physiology and Diseases: Implications for Diagnosis and Treatment.细胞外囊泡在甲状腺生理与疾病中的作用:对诊断和治疗的启示
Biomedicines. 2022 Oct 15;10(10):2585. doi: 10.3390/biomedicines10102585.
甲状腺乳头状癌的预后:一个不断发展的领域。
Cancers (Basel). 2021 Nov 7;13(21):5567. doi: 10.3390/cancers13215567.
4
Diagnostic and Prognostic Performance of Liquid Biopsy-Derived Exosomal MicroRNAs in Thyroid Cancer Patients: A Systematic Review and Meta-Analysis.液体活检来源的外泌体微小RNA在甲状腺癌患者中的诊断和预后性能:一项系统评价和荟萃分析
Cancers (Basel). 2021 Aug 26;13(17):4295. doi: 10.3390/cancers13174295.
5
Analysis of serum microRNA in exosomal vehicles of papillary thyroid cancer.甲状腺乳头癌囊泡外体血清 microRNA 分析。
Endocrine. 2022 Jan;75(1):185-193. doi: 10.1007/s12020-021-02847-2. Epub 2021 Aug 10.
6
miR-221-3p and miR-222-3p regulate the SOCS3/STAT3 signaling pathway to downregulate the expression of NIS and reduce radiosensitivity in thyroid cancer.miR-221-3p和miR-222-3p调节SOCS3/STAT3信号通路,以下调甲状腺癌中NIS的表达并降低放射敏感性。
Exp Ther Med. 2021 Jun;21(6):652. doi: 10.3892/etm.2021.10084. Epub 2021 Apr 19.
7
Brij-stabilized zein nanoparticles as potential drug carriers.Brij 稳定的玉米醇溶蛋白纳米粒作为潜在的药物载体。
Colloids Surf B Biointerfaces. 2021 May;201:111647. doi: 10.1016/j.colsurfb.2021.111647. Epub 2021 Feb 19.
8
Exosomal hsa-miR-129-2 and hsa-miR-889 from a 6-microRNA Signature Might be a Potential Biomarker for Predicting the Prognosis of Papillary Thyroid Carcinoma.6 种微小 RNA 特征的外泌体 hsa-miR-129-2 和 hsa-miR-889 可能是预测甲状腺乳头状癌患者预后的潜在生物标志物。
Comb Chem High Throughput Screen. 2022;25(5):819-830. doi: 10.2174/1386207324666210125110732.
9
MicroRNA Deregulation in Papillary Thyroid Cancer and its Relationship With BRAF V600E Mutation.甲状腺乳头癌中 microRNA 的失调及其与 BRAF V600E 突变的关系。
In Vivo. 2021 Jan-Feb;35(1):319-323. doi: 10.21873/invivo.12262.
10
Decreased serum exosomal miR-29a expression and its clinical significance in papillary thyroid carcinoma.血清外泌体 miR-29a 表达降低及其在甲状腺乳头状癌中的临床意义。
J Clin Lab Anal. 2021 Jan;35(1):e23560. doi: 10.1002/jcla.23560. Epub 2020 Dec 23.